Clinical and functional characterization of a long survivor congenital titinopathy patient with a novel metatranscript-only titin variant.
Congenital myopathy
Metatranscript
N2A titin isoform
Rigid spine
Single fiber studies
Splicing
Titin
Titinopathy
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
21 03 2023
21 03 2023
Historique:
received:
06
02
2023
accepted:
03
03
2023
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
24
3
2023
Statut:
epublish
Résumé
Congenital titinopathies are an emerging group of a potentially severe form of congenital myopathies caused by biallelic mutations in titin, encoding the largest existing human protein involved in the formation and stability of sarcomeres. In this study we describe a patient with a congenital myopathy characterized by multiple contractures, a rigid spine, non progressive muscular weakness, and a novel homozygous TTN pathogenic variant in a metatranscript-only exon: the c.36400A > T, p.Lys12134*. Muscle biopsies showed increased internalized nuclei, variability in fiber size, mild fibrosis, type 1 fiber predominance, and a slight increase in the number of satellite cells. RNA studies revealed the retention of intron 170 and 171 in the open reading frame, and immunoflourescence and western blot studies, a normal titin content. Single fiber functional studies showed a slight decrease in absolute maximal force and a cross-sectional area with no decreases in tension, suggesting that weakness is not sarcomere-based but due to hypotrophy. Passive properties of single fibers were not affected, but the observed increased calcium sensitivity of force generation might contribute to the contractural phenotype and rigid spine of the patient. Our findings provide evidence for a pathogenic, causative role of a metatranscript-only titin variant in a long survivor congenital titinopathy patient with distal arthrogryposis and rigid spine.
Identifiants
pubmed: 36945066
doi: 10.1186/s40478-023-01539-4
pii: 10.1186/s40478-023-01539-4
pmc: PMC10031982
doi:
Substances chimiques
Connectin
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
48Informations de copyright
© 2023. The Author(s).
Références
J Biomed Biotechnol. 2010;2010:753675
pubmed: 20339475
Neuropediatrics. 2022 Oct;53(5):309-320
pubmed: 35605965
J Neuropathol Exp Neurol. 2018 Dec 1;77(12):1101-1114
pubmed: 30365001
Circ Res. 2001 Nov 23;89(11):1065-72
pubmed: 11717165
Ann Neurol. 2015 Dec;78(6):982-994
pubmed: 26418456
Ann Neurol. 2018 Jun;83(6):1105-1124
pubmed: 29691892
Ann Clin Transl Neurol. 2020 May;7(5):846-854
pubmed: 32307885
Skelet Muscle. 2018 Mar 29;8(1):11
pubmed: 29598826
Front Physiol. 2016 Nov 15;7:520
pubmed: 27895589
Genome Res. 2020 Jun;30(6):885-897
pubmed: 32660935
J Neuromuscul Dis. 2016 Aug 30;3(3):293-308
pubmed: 27854229
Neuromuscul Disord. 2020 Nov;30(11):877-887
pubmed: 33127292
Genet Med. 2020 Dec;22(12):2029-2040
pubmed: 32778822
Eur J Hum Genet. 2019 Mar;27(3):349-352
pubmed: 30552423
Brain. 2013 Feb;136(Pt 2):494-507
pubmed: 23378224
Neuromuscul Disord. 2017 Feb;27(2):188-192
pubmed: 28040389
Hum Mutat. 2020 Feb;41(2):403-411
pubmed: 31660661
Circ Res. 2004 Feb 20;94(3):284-95
pubmed: 14976139
Adv Protein Chem. 2005;71:89-119
pubmed: 16230110